Removal of Arg141 from the α chain of human hemoglobin by carboxypeptidases N and M

Circulation Research

Volumn 78, Issue 4, 1996, Pages 635-642

  Michel, Bruno ^a   Igić, Rajko ^b   Leray, Valérie ^a   Deddish, Peter A ^a   Erdös, Ervin G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

Blood substitutes; Carboxypeptidases; Coronary vasoconstriction; Cross linked hemoglobin; Oxygen affinity

Indexed keywords

ARGININE CARBOXYPEPTIDASE; CARBOXYPEPTIDASE M; CROSS LINKING REAGENT; DEOXY DES ALPHA ARGININE(141) HEMOGLOBIN; DEOXY-DES-ALPHA-ARGININE(141) HEMOGLOBIN; DEOXYHEMOGLOBIN; HEMOGLOBIN; METALLOPROTEINASE; OXYGEN; OXYHEMOGLOBIN; 2,3 DIPHOSPHOGLYCERIC ACID; ARGINASE; ARGININE; CARBOXYPEPTIDASE; HAPTOGLOBIN; ORNITHINE; UNCLASSIFIED DRUG;

ADULT; ANIMAL; ARTERY; ARTICLE; CORONARY BLOOD VESSEL; DRUG EFFECT; HUMAN; HYDROLYSIS; KINETICS; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; BINDING AFFINITY; DOSE RESPONSE; NONHUMAN; OXYGEN AFFINITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; VASOCONSTRICTION;

ADULT; ANIMALS; ARTERIES; CORONARY VESSELS; CROSS-LINKING REAGENTS; HEMOGLOBINS; HUMANS; HYDROLYSIS; KINETICS; LYSINE CARBOXYPEPTIDASE; MALE; METALLOENDOPEPTIDASES; OXYGEN; OXYHEMOGLOBINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029664517     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.res.78.4.635     Document Type: Article

References (48)

1. Jones JA. Red blood cell substitutes: current status. Br J Anaesth. 1995;74:697-703.
2. International Hemoglobin Information Center variant list. Hemoglobin. 1995;19:37-39.
3. Zito R, Antonini E, Wyman J. The effect of oxygenation on the rate of digestion of human hemoglobins by carboxypeptidases. J Biol Chem. 1964;239:1804-1808.
4. Fasan G, Grandgeorge M, Vigneron C, Dellacherie E. Preparation of unaltered hemoglobin from human placentas for possible use in blood substitutes. J Biochem Biophys Methods. 1991;23:53-66.
5. Perutz MF. Stereochemistry of cooperative effects in haemoglobin: haem-haem interaction and the problem of allostery. Nature. 1970; 228:726-734.
6. Perutz MF. Stereochemistry of cooperative effects in haemoglobin: the Bohr effect and combination with organic phosphates. Nature. 1970;228:734-739.
7. Skidgel RA, Davis RM, Tan F. Human carboxypeptidase M: purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem. 1989;264: 2236-2241.
8. Skidgel RA. Structure and function of mammalian zinc carboxypeptidases. In: Hooper NM, ed. Zinc Metalloproteases in Health and Disease. London, UK: Taylor and Francis. In press.
9. Johnson AR, Skidgel RA, Gafford JT, Erdös EG. Enzymes in placental microvilli: angiotensin I converting enzyme, angiotensinase A, carboxypeptidase, and neutral endopeptidasc ("enkephalinasc"). Peptides. 1984;5:789-796.
10. Tan F, Weerasinghe DK, Skidgel RA, Tamei H, Kaul RK, Roninson I, Schilling JW, Erdös EG. The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats. J Biol Chem. 1990;265:13-19.
11. Levin Y, Skidgel RA, Erdös EG. Isolation and characterization of the subunits of human plasma carboxypeptidase N. Proc Natl Acad Sci USA. 1982;79:4618-4622.
12. Evelyn KA, Malloy HT. Microdetermination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in a single sample of blood. J Biol Chem. 1938;126:655-662.
13. Oshima E, Kato J, Erdös EG. Plasma carboxypeptidase N, subunits and characteristics. Arch Biochem Biophys. 1975;170:132-138.
14. Skidgel RA. Assays for arginine/lysine carboxypeptidases: carboxypeptidases H (E; enkephalin convertase), M and N. Methods Neurosci. 1991;6:373-385.
15. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72:248-254.
16. Erdös EG, Renfrew AG, Sloane EM, Wohler JR. Enzymatic studies on bradykinin and similar peptides. Ann NY Acad Sci. 1963; 104:222-234.
17. Ip SHC, Johnson ML, Ackers GK. Kinetics of deoxyhemoglobin subunit dissociation determined by haptoglobin binding: estimation of the equilibrium constant from forward and reverse rates. Biochemistry. 1976;15:654-660.
18. 2 dissociation computations. J Appl Physiol. 1979;46:599-602.
19. Zygmunt D, Labrude P, Vigneron C. Structure and functional properties of oxyhaemoglobin regenerated from methaemoglobin obtained chemically or by freeze-drying. Int J Biol Macromol. 1987; 9:197-204.
20. Doring HJ, Dehnert H. The Isolated Perfused Heart According to Langendorff. Germany: Biomesstechnik-Verlag GmbH; 1988:1-131.
21. 2 lysyl residues by bis(3,5-dibromosalicyl)-fumarate. Biochemistry. 1991;30:8158-8165.
22. Freas W, Llave R, Jing M, Hart J, McQuillan P, Muldoon S. Contractile effects of diaspirin cross-linked hemoglobin (DCLHb) on isolated porcine blood vessels. J Lab Clin Med. 1995;125: 762-767.
23. Kilmartin JV, Hewitt JA, Wootton JF. Alteration of functional properties associated with the change in quaternary structure in unliganded haemoglobin. J Mol Biol 1975;93:203-218.
24. 2). J Biol Chem. 1986;261:9929-9937.
25. Cody WL, Doherty AM. The development of potent peptide agonists and antagonists for the endothelin receptors. Biopolymers. 1995;37:89-104.
26. Steele JA, Stockbridge N, Maljkovic G, Weir B. Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circ Res. 1991;68:416-423.
27. Moncada S, Palmer FMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43: 109-142.
28. Wellum GR, Irvine TW, Zervas NT. Cerebral vasoactivity of heme proteins in vitro: some mechanistic considerations. J Neurosurg. 1982;56:777-783.
29. Edelstein SJ, Rehmar MJ, Olson JS, Gibson OH. Functional aspects of the subunit association-dissociation equilibria of hemoglobin. J Biol Chem. 1970;245:4372-4381.
30. Ham TH. Hemoglobinuria. Am J Med. 1955:990-1006.
31. 2. Acta Haematol. 1967;37:174-180.
32. MacDonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971-982.
33. Vogel WM, Dennis RC, Cassidy G, Apstein CS, Valeri CR. Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol. 1986;251:H413-H420.
34. Nees JE, Hauser CJ, Shippy C, State D, Shoemaker WC. Comparison of cardiorespiratory effects of crystalline hemoglobin, whole blood, albumin, and Ringer's lactate in the resuscitation of hemorrhagic shock in dogs. Surgery. 1978;83:639-647.
35. Cocks TM, Malta E, King SJ, Woods RL, Angus JA. Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol. 1991;196:177-182.
36. Gulati A, Singh G, Rebello S, Sharma AC. Effect of diaspirin cross-linked and stroma-reduced hemoglobin on mean arterial pressure and endothelin-1 concentration in rats. Life Sci. 1995;56:1433-1442.
37. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med. 1993;122: 301-308.
38. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
39. Hermann L. Ueber die wirkungen des stickstoffoxydgases auf das blut. In: Reichert CB, Du Bois-Reymond E, eds. Archiv für Anatomie Physiologie und Wissenschaftliche Medicin. Leipzig, Germany: Verlag; 1865:469-481.
40. Gibson QH, Roughton FJW. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol. 1957; 136:507-526.
41. Tanishima T. Cerebral vasospasm: contractile activity of hemoglobin in isolated canine basilar arteries. J Neurosurg. 1980;53: 787-793.
42. Beny J-L, Brunet PC, Van der Bent V. Hemoglobin causes both endothelium-dependent and endothelium-independent contraction of the pig coronary arteries, independently of an inhibition of EDRF effects. Experientia. 1989;45:132-134.
43. Tan F, Chan SJ, Steiner DF, Schilling JW, Skidgel RA. Molecular cloning and sequencing of the cDNA for human membrane-bound carboxypeptidase M: comparison with carboxypeptidases A, B, H, and N. J Biol Chem. 1989;264:13165-13170.
44. Abendschein DR, Serota H, Plummer TH Jr, Amiraian K, Strauss AW, Sobel BE, Jaffe AS. Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N. J Lab Clin Med. 1987;110:798-806.
45. 53-EGF by carboxypeptidase M. J Biol Chem. 1995;270:17154-17158.
46. Rehli M, Krause SW, Kreutz M, Andreesen R. Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J Biol Chem. 1995; 270:15644-15649.
47. Nagae A, Deddish PA, Becker RP, Anderson CH, Abe M, Tan F, Skidgel RA, Erdös EG. Carboxypeptidase M in brain and peripheral nerves. J Neurochem. 1992;59:2201-2212.
48. Nagae A, Abe M, Becker RP, Deddish PA, Skidgel RA, Erdös EG. High concentration of carboxypeptidase M in lungs: presence of the enzyme in alveolar type I cells. Am J Respir Cell Mol Biol. 1993;9: 221-229.